• 1 of 1

As healthcare professionals prepare for blockbuster biologic Humira to come off patent on 16 October 2018, we highlight what pharmacists need to know about switching from originator biologics to biosimilars in order to get best value from these medicines

The patent on Humira (adalimumab) expires in October 2018, and a further 17 important biologics are estimated to be coming off patent by 2023

Source  Alamy